What are the Historical Developments and Current Growth Metrics of the Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logistics market has seen considerable growth due to a variety of factors.
•The market size of the cell and gene therapy supply chain/logistics field has expanded swiftly in the last few years. The market is projected to increase from $1.41 billion in 2024 to $1.58 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.8%.
This growth during the historical period can be linked to the rising incidence of chronic diseases, effective supply chain management, enhanced drug integrity maintenance, updated regulatory guidelines, and a greater focus on risk reduction and adherence.
What Does Future Hold for The Cell And Gene Therapy Supply Chain/Logistics Market Size?
The cell and gene therapy supply chain/logistics market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for a quick expansion in the cell and gene therapy supply chain/logistics market over the ensuing years. An estimated growth of $2.44 billion by 2029, which represents a compound annual growth rate (CAGR) of 11.5%,
is projected for this market. This surge during the prediction period can be linked to the growth of personalized medicine, the rise of cell-free therapies, the increasing incidence of chronic diseases, the expansion of the global cell therapy manufacturing market, and effective adherence to supply chain requirements. Notable trends for the forecast period involve an increase in research and development expenditure, adoption of cutting-edge technologies, beneficial initiatives and schemes for easier accessibility, strategic partnerships and alliances among cell and gene therapy companies, supply chain providers, and logistics companies, as well as offering flexible services to aid any stage of patient identification.
What Key Factors and Trends are Driving the Growth of the Cell And Gene Therapy Supply Chain/Logistics Market?
The escalating demand for cell and gene treatments is fueling the growth of the cell and gene therapy supply chain, also known as the logistics market. As advanced medical procedures, cell and gene therapies involve altering cells or genes to combat diseases, thereby providing potential remedial breakthroughs for previously incurable conditions. To ensure the effectiveness of these therapies, it is critical that they are stored under appropriate temperature and storage conditions, a feat made possible through logistics services that oversee everything from sourcing to distribution and storage. As reported by the American Society of Gene & Cell Therapy, a U.S.-based non-profit health and science organization, the number of gene therapies in Phase III clinical trials witnessed a growth of 10% in Q3 2023, marking the first quarterly rise since Q3 2022. This escalating demand for cell and gene therapies, therefore, propels the cell and gene therapy supply chain or logistics market.
What are the Market Segments in the Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
Pre-Book The Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Cell And Gene Therapy Supply Chain/Logistics Market?
The increase in popularity of modern technological platforms in the cell and gene therapy supply chain/logistics markets is a primary trend. Several big companies within the market are creating these modern platforms to uphold their market status in the arena of cell and gene therapies. To illustrate, AmerisourceBergen Corporation., a healthcare company based in the US known for its specialism in cell and gene therapy supply chain logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This CGT Integration Hub employs AmerisourceBergen's inventive customer relationship management (CRM) system and can be incorporated into the biopharma platform, thereby enabling enhanced supervision of the progression and distribution of cell and gene therapies.
Who Are the Key Players in the Cell And Gene Therapy Supply Chain/Logistics Market?
Major companies operating in the cell and gene therapy supply chain/logistics market include:
• AmerisourceBergen Corporation
• United Parcel Service
• Thermo Fisher Scientific Inc.
• Avantor Sciences
• Lonza Group AG
• Arvato Group
• Catalent Inc.
• Charles River Laboratories International
• Parexel International Corporation
• Cytiva
• Almac Group
• World Courier
• Sharp Packaging Services
• PCI Pharma Services
• Cryoport Inc.
• Brooks Life Sciences
• BioLife Solutions Inc.
• Biocair Inc.
• QuickSTAT
• Clarkston Consulting Inc.
• Central Pharma
• TrakCel limited
• MAK-SYSTEM International Group
• Hypertrust Patient Data Care GmbH
• Atelerix Ltd.
• Polar Express Transportation
• Be The Match BioTherapies Inc.
• Yourway Biopharma Services Company
• Azenta Life Sciences Inc.
• Biostor Ltd.
What are the Regional Insights into the Cell And Gene Therapy Supply Chain/Logistics Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
